Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr-Jun;64(2):85-95.

Evaluating glaucoma surgeries in the MIGS context

Deepika Dhingra  1 , Shibal Bhartiya  2
Affiliations
Review

Evaluating glaucoma surgeries in the MIGS context

Deepika Dhingra et al. Rom J Ophthalmol. 2020 Apr-Jun.

Abstract

The challenges of glaucoma management are many: the disease is chronic, progressive, often asymptomatic, and very often, the quality of life and costs of treatment is unacceptable to the patient. This is true for both medical therapy and conventional glaucoma surgery. The choice of therapy, especially the transition from the former to the latter, is now being bridged by Minimally Invasive Glaucoma Surgeries (MIGS). Choosing from the several options now available in the surgical armamentarium requires a deeper understanding of the available modalities. This review aims to provide an overview of the decision-making process, keeping in mind age, type of glaucoma, life expectancy, socioeconomic status, patient expectations, and coexisting cataract.

Keywords: MIGS; glaucoma; glaucoma drainage device; minimally invasive glaucoma surgery; trabeculectomy.

PubMed Disclaimer

References

    1. Ansari E. An update on implants for minimally invasive glaucoma surgery (MIGS) Ophthalmol Ther. 2017;6:233–241. - PMC - PubMed
    1. Vahedian Z, Mafi M, Fakhraie G, Zarei R, Eslami Y, Ghadimi H, Mohebbi M. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial. J Glaucoma. 2017;26:829–834. - PubMed
    1. El-Sayyad F, El-Saied HMA, Abdelhakim MASE. Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study. Ophthalmic Res. 2017;57:230–238. - PubMed
    1. Tanna AP, Rademaker AW, de Moraes CG, Godfrey DG, Sarkisian SR Jr, Vold SD, Ritch R. Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. BMC Ophthalmol. 2016;16:217. - PMC - PubMed
    1. Wlaź A, Wilkos-Kuc A, Rozegnał-Madej A, Żarnowski T. Phacotrabeculectomy using collagen matrix implant (Ologen(®) ) versus mitomycin C: a prospective randomized controlled trial. Acta Ophthalmol. 2019;97:e817–e826. - PubMed

MeSH terms

LinkOut - more resources